NEWTON, Mass.--(BUSINESS WIRE)--Agilent Technologies, Inc., (NYSE: A) and Cogenics, a division of Clinical Data, Inc. (NASDAQ: CLDA), today announced that Cogenics is the first Certified Microarray Service Provider for Agilent’s microRNA (miRNA) microarrays. With this certification Cogenics becomes the initial service provider to offer expression profiling of miRNA on the Agilent platform, giving scientists in research institutions and drug discovery programs immediate access to this important tool for understanding gene regulation.
